Latest filing published 06 Apr 2026 for Raphael Pharmaceutical Inc., €3,033.
Insider track record
Hayon Igal Louria: trading record in brief
This profile gathers the share dealings of Hayon Igal Louria in Raphael Pharmaceutical Inc. Over a trading history stretching from 29 August 2023 to 20 November 2025, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 6 April 2026 with a share grant (€3,033) in Raphael Pharmaceutical Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Hayon Igal Louria
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 350,000 shares@ US$0.0124.8% of flowCommon StockSEC:0001213900-26-040590:0
- 999,000 shares@ US$0.0175.2% of flowCommon StockSEC:0001213900-24-025519:0
2 of 2 declarations